Rep. Lisa C. McClain Purchases Shares of Becton, Dickinson and Company (NYSE:BDX)

Key Points

• Representative Lisa C. McClain purchased shares in Becton, Dickinson and Company (NYSE: BDX) for between $1,001 and $15,000 on June 17th, reflecting her investment interest in the medical instruments supplier.
• Becton, Dickinson and Company reported better-than-expected earnings with $3.68 EPS for the latest quarter, surpassing the consensus estimate of $3.40, alongside a revenue increase of 10.4% year-over-year.
• The company has announced a quarterly dividend of $1.04 per share, indicating a healthy dividend yield of 2.1% while maintaining a payout ratio of 74.82%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Becton, Dickinson and Company NYSE: BDX. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Becton, Dickinson and Company stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Becton, Dickinson and Company Stock Up 1.5%

Shares of BDX traded up $2.8730 during trading hours on Friday, hitting $199.5030. The stock had a trading volume of 1,619,788 shares, compared to its average volume of 2,720,196. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.10 and a quick ratio of 0.62. The firm has a 50 day simple moving average of $180.65 and a 200-day simple moving average of $195.26. The firm has a market capitalization of $57.18 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 1.49 and a beta of 0.20. Becton, Dickinson and Company has a 1-year low of $163.33 and a 1-year high of $251.99.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 EPS for the quarter, beating the consensus estimate of $3.40 by $0.28. The company had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.50 billion. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%.The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $3.50 EPS. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. Sell-side analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 8th will be issued a dividend of $1.04 per share. This represents a $4.16 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Monday, September 8th. Becton, Dickinson and Company's dividend payout ratio (DPR) is presently 74.82%.

Insider Transactions at Becton, Dickinson and Company

In other news, EVP Michael David Garrison sold 1,185 shares of the business's stock in a transaction that occurred on Friday, July 18th. The stock was sold at an average price of $180.29, for a total value of $213,643.65. Following the transaction, the executive vice president owned 4,887 shares in the company, valued at $881,077.23. The trade was a 19.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Claire Fraser sold 863 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $192.30, for a total value of $165,954.90. Following the completion of the transaction, the director owned 23,143 shares in the company, valued at $4,450,398.90. The trade was a 3.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,214 shares of company stock worth $579,206 in the last 90 days. Insiders own 0.36% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Morgan Stanley raised their target price on Becton, Dickinson and Company from $196.00 to $197.00 and gave the company an "overweight" rating in a research note on Monday, August 11th. Wells Fargo & Company raised their target price on Becton, Dickinson and Company from $172.00 to $184.00 and gave the company an "equal weight" rating in a research note on Friday, August 8th. Wall Street Zen upgraded Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Bank of America downgraded Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $190.00 target price for the company. in a research note on Thursday, May 1st. Finally, Stifel Nicolaus reduced their target price on Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Four investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $211.44.

Hedge Funds Weigh In On Becton, Dickinson and Company

Several large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in shares of Becton, Dickinson and Company by 15.4% in the 2nd quarter. Vanguard Group Inc. now owns 32,308,749 shares of the medical instruments supplier's stock worth $5,565,182,000 after buying an additional 4,305,947 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in shares of Becton, Dickinson and Company by 3.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 12,575,351 shares of the medical instruments supplier's stock worth $2,880,510,000 after buying an additional 448,644 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in shares of Becton, Dickinson and Company by 59.2% in the 2nd quarter. First Eagle Investment Management LLC now owns 8,786,190 shares of the medical instruments supplier's stock worth $1,513,421,000 after buying an additional 3,268,478 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Becton, Dickinson and Company by 24.4% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,514,446 shares of the medical instruments supplier's stock worth $1,466,613,000 after buying an additional 1,670,590 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Becton, Dickinson and Company by 3.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,723,702 shares of the medical instruments supplier's stock worth $1,153,157,000 after buying an additional 244,199 shares during the last quarter. Institutional investors own 86.97% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.